Last Updated: August 9, 2026

Details for Patent: 9,931,304

Name: Drug Patent Intelligence for US Patent 9931304
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,931,304

Title:	Method of making particles for use in a pharmaceutical composition
Abstract:	The invention relates to a method for making composite active particles for use in a pharmaceutical composition for pulmonary administration, the method comprising a milling step in which particles of active material are milled in the presence of particles of an additive material which is suitable for the promotion of the dispersal of the composite active particles upon actuation of an inhaler. The invention also relates to compositions for inhalation prepared by the method.
Inventor(s):	John Nicholas Staniforth, Matthew Michael Green, David Alexander Vodden Morton
Assignee:	Vectura Ltd
Application Number:	US14/553,187
Patent Claim Types: see list of patent claims	Composition; Delivery;
Patent landscape, scope, and claims:	error: insufficient information More… ↓ ⤷ Start Trial

Drugs Protected by US Patent 9,931,304

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 9,931,304

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0029261.5	Nov 30, 2000
United Kingdom	0030946.8	Dec 19, 2000
	PCT/GB01/01606	Apr 9, 2001
United Kingdom	0124010.0	Oct 5, 2001

International Family Members for US Patent 9,931,304

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1267866	⤷ Start Trial	C300583	Netherlands	⤷ Start Trial
European Patent Office	1267866	⤷ Start Trial	CA 2013 00015	Denmark	⤷ Start Trial
European Patent Office	1267866	⤷ Start Trial	92166	Luxembourg	⤷ Start Trial
European Patent Office	1267866	⤷ Start Trial	C300651	Netherlands	⤷ Start Trial
European Patent Office	1267866	⤷ Start Trial	CA 2014 00020	Denmark	⤷ Start Trial
European Patent Office	1267866	⤷ Start Trial	92393	Luxembourg	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.